86 related articles for article (PubMed ID: 9661083)
1. A dual-label immunofluorometric assay for human osteocalcin.
Ylikoski A; Hellman J; Matikainen T; Käkönen SM; Karp M; Väänänen HK; Lövgren T; Pettersson K
J Bone Miner Res; 1998 Jul; 13(7):1183-90. PubMed ID: 9661083
[TBL] [Abstract][Full Text] [Related]
2. Epitope mapping of nine monoclonal antibodies against osteocalcin: combinations into two-site assays affect both assay specificity and sample stability.
Hellman J; Käkönen SM; Matikainen MT; Karp M; Lövgren T; Väänänen HK; Pettersson K
J Bone Miner Res; 1996 Aug; 11(8):1165-75. PubMed ID: 8854253
[TBL] [Abstract][Full Text] [Related]
3. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro.
Garnero P; Grimaux M; Seguin P; Delmas PD
J Bone Miner Res; 1994 Feb; 9(2):255-64. PubMed ID: 8140939
[TBL] [Abstract][Full Text] [Related]
4. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay.
Garnero P; Grimaux M; Demiaux B; Preaudat C; Seguin P; Delmas PD
J Bone Miner Res; 1992 Dec; 7(12):1389-98. PubMed ID: 1481725
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum.
Käkönen SM; Hellman J; Karp M; Laaksonen P; Obrant KJ; Väänänen HK; Lövgren T; Pettersson K
Clin Chem; 2000 Mar; 46(3):332-7. PubMed ID: 10702519
[TBL] [Abstract][Full Text] [Related]
6. Validation of a new automated immunoassay for measurement of intact osteocalcin.
Fassbender WJ; Steinhauer B; Stracke H; Schumm-Draeger PM; Usadel KH
Clin Lab; 2002; 48(1-2):31-8. PubMed ID: 11833673
[TBL] [Abstract][Full Text] [Related]
7. Homogeneous dual-parameter assay for prostate-specific antigen based on fluorescence resonance energy transfer.
Kokko T; Liljenbäck T; Peltola MT; Kokko L; Soukka T
Anal Chem; 2008 Dec; 80(24):9763-8. PubMed ID: 19012418
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of the predominant urine osteocalcin fragments detectable by two-site immunoassays.
Matikainen T; Käkönen SM; Pettersson K; Karp M; Lövgren T; Väänänen Hk; Hellman J
J Bone Miner Res; 1999 Mar; 14(3):431-8. PubMed ID: 10027908
[TBL] [Abstract][Full Text] [Related]
9. The proportion of carboxylated to total or intact osteocalcin in serum discriminates warfarin-treated patients from control subjects.
Obrant KJ; Käkönen SM; Astermark J; Lilja H; Lövgren T; Akesson K; Pettersson K
J Bone Miner Res; 1999 Apr; 14(4):555-60. PubMed ID: 10234576
[TBL] [Abstract][Full Text] [Related]
10. Two-site enzyme immunoassay for measuring intact human osteocalcin in serum.
Parviainen M; Kuronen I; Kokko H; Lakaniemi M; Savolainen K; Mononen I
J Bone Miner Res; 1994 Mar; 9(3):347-54. PubMed ID: 8191928
[TBL] [Abstract][Full Text] [Related]
11. Immunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and streptavidin-biotin technology.
Huhtinen P; Soukka T; Lövgren T; Härmä H
J Immunol Methods; 2004 Nov; 294(1-2):111-22. PubMed ID: 15604021
[TBL] [Abstract][Full Text] [Related]
12. Validation of an ultrasensitive and specific immunofluorometric assay for mouse follicle-stimulating hormone.
Jimenez M; Spaliviero JA; Grootenhuis AJ; Verhagen J; Allan CM; Handelsman DJ
Biol Reprod; 2005 Jan; 72(1):78-85. PubMed ID: 15342359
[TBL] [Abstract][Full Text] [Related]
13. A time-resolved immunofluorometric assay for quantification of the bovine collectin conglutinin.
Krogh-Meibom T; Holmskov U; Løvendahl P; Nielsen NI; Ingvartsen KL
J Immunol Methods; 2004 Mar; 286(1-2):87-96. PubMed ID: 15087224
[TBL] [Abstract][Full Text] [Related]
14. Comparison of monoclonal and polyclonal antibody-based immunoassays for osteocalcin: a study of sources of variation in assay results.
Tracy RP; Andrianorivo A; Riggs BL; Mann KG
J Bone Miner Res; 1990 May; 5(5):451-61. PubMed ID: 2368627
[TBL] [Abstract][Full Text] [Related]
15. A time-resolved immunofluorometric assay for quantification of collectin-43.
Krogh-Meibom T; Holmskov U; Løvendahl P; Ingvartsen KL
J Immunol Methods; 2004 Dec; 295(1-2):161-7. PubMed ID: 15627621
[TBL] [Abstract][Full Text] [Related]
16. Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women.
Chen JT; Hosoda K; Hasumi K; Ogata E; Shiraki M
J Bone Miner Res; 1996 Nov; 11(11):1784-92. PubMed ID: 8915787
[TBL] [Abstract][Full Text] [Related]
17. Highly sensitive time-resolved fluoroimmunoassay of human immunoglobulin E by using a new europium fluorescent chelate as a label.
Yuan J; Wang G; Kimura H; Matsumoto K
Anal Biochem; 1997 Dec; 254(2):283-7. PubMed ID: 9417790
[TBL] [Abstract][Full Text] [Related]
18. Comparison of homogeneous single-label fluorometric binding assays: fluorescence polarization and dual-parametric quenching resonance energy transfer technique.
Härmä H; Sarrail G; Kirjavainen J; Martikkala E; Hemmilä I; Hänninen P
Anal Chem; 2010 Feb; 82(3):892-7. PubMed ID: 20047278
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of alpha-fetoprotein and carcinoembryonic antigen in human serum by time-resolved fluoroimmunoassay.
Matsumoto K; Yuan J; Wang G; Kimura H
Anal Biochem; 1999 Dec; 276(1):81-7. PubMed ID: 10585747
[TBL] [Abstract][Full Text] [Related]
20. [Serum osteocalcin in children with chronic renal insufficiency].
Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
